| ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on expert consensus documents and the … VV McLaughlin, SL Archer, DB Badesch, RJ Barst, HW Farber, JR Lindner, ... Journal of the American college of cardiology 53 (17), 1573-1619, 2009 | 3505 | 2009 |
| Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the … MR Jaff, MS McMurtry, SL Archer, M Cushman, N Goldenberg, ... Circulation 123 (16), 1788-1830, 2011 | 2516 | 2011 |
| Cellular and molecular pathobiology of pulmonary arterial hypertension M Humbert, NW Morrell, SL Archer, KR Stenmark, MR MacLean, IM Lang, ... Journal of the American College of Cardiology 43 (12S), S13-S24, 2004 | 2181 | 2004 |
| A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth S Bonnet, SL Archer, J Allalunis-Turner, A Haromy, C Beaulieu, ... Cancer cell 11 (1), 37-51, 2007 | 1997 | 2007 |
| Measurement of nitric oxide in biological models S Archer The FASEB journal 7 (2), 349-360, 1993 | 1315 | 1993 |
| Mitochondrial dynamics—mitochondrial fission and fusion in human diseases SL Archer New England Journal of Medicine 369 (23), 2236-2251, 2013 | 1203 | 2013 |
| Cellular and molecular basis of pulmonary arterial hypertension NW Morrell, S Adnot, SL Archer, J Dupuis, P Lloyd Jones, MR MacLean, ... Journal of the American College of Cardiology 54 (1_Supplement_S), S20-S31, 2009 | 1083 | 2009 |
| Pediatric pulmonary hypertension: guidelines from the American heart association and American thoracic society SH Abman, G Hansmann, SL Archer, DD Ivy, I Adatia, WK Chung, ... Circulation 132 (21), 2037-2099, 2015 | 1075 | 2015 |
| Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. SL Archer, JM Huang, V Hampl, DP Nelson, PJ Shultz, EK Weir Proceedings of the National Academy of Sciences 91 (16), 7583-7587, 1994 | 1060 | 1994 |
| Pulmonary arterial hypertension: pathogenesis and clinical management T Thenappan, ML Ormiston, JJ Ryan, SL Archer Bmj 360, 2018 | 939 | 2018 |
| Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide E Michelakis, W Tymchak, D Lien, L Webster, K Hashimoto, S Archer Circulation 105 (20), 2398-2403, 2002 | 785 | 2002 |
| An abnormal mitochondrial–hypoxia inducible factor-1α–Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities … S Bonnet, ED Michelakis, CJ Porter, MA Andrade-Navarro, B Thébaud, ... Circulation 113 (22), 2630-2641, 2006 | 683 | 2006 |
| Relevant issues in the pathology and pathobiology of pulmonary hypertension RM Tuder, SL Archer, P Dorfmüller, SC Erzurum, C Guignabert, ... Journal of the American College of Cardiology 62 (25S), D4-D12, 2013 | 682 | 2013 |
| Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies SL Archer, EK Weir, MR Wilkins Circulation 121 (18), 2045-2066, 2010 | 654 | 2010 |
| Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility J Nagendran, SL Archer, D Soliman, V Gurtu, R Moudgil, A Haromy, ... Circulation 116 (3), 238-248, 2007 | 632 | 2007 |
| Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer J Rehman, HJ Zhang, PT Toth, Y Zhang, G Marsboom, Z Hong, R Salgia, ... The FASEB Journal 26 (5), 2175, 2012 | 625 | 2012 |
| Acute oxygen-sensing mechanisms EK Weir, J López-Barneo, KJ Buckler, SL Archer New England Journal of Medicine 353 (19), 2042-2055, 2005 | 625 | 2005 |
| Hypoxic pulmonary vasoconstriction R Moudgil, ED Michelakis, SL Archer Journal of applied physiology 98 (1), 390-403, 2005 | 619 | 2005 |
| Direct role for potassium channel inhibition in hypoxic pulmonary vasoconstriction JM Post, JR Hume, SL Archer, EK Weir American Journal of Physiology-Cell Physiology 262 (4), C882-C890, 1992 | 600 | 1992 |
| The mechanism of acute hypoxic pulmonary vasoconstriction: the tale of two channels EK Weir, SL Archer The FASEB journal 9 (2), 183-189, 1995 | 580 | 1995 |
Edward K. WeirProfessor of Medicine, University of MinnesotaZweryfikowany adres z umn.edu